Skip to search formSkip to main contentSkip to account menu

NRX 194204

Known as: NRX-194204, NRX194204, Rexinoid NRX 194204 
An orally bioavailable synthetic retinoid X receptor (RXR) agonist with potential antineoplastic and anti-inflammatory activities. Rexinoid NRX… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Two major unresolved issues for breast cancer prevention are the lack of effective preventive agents for estrogen receptor (ER… 
2013
2013
APELACAO CIVEL/REEXAME NECESSARIO No 1.0042.11.000016-5/002 - Comarca de Arcos - Remetente: Juiz de Direito da 1a Vara Civel… 
2010
2010
Downlo creatic cancer is the fourth leading cause of cancer-related deaths in the United States and is nearly s fatal. Whereas… 
2010
2010
Downlo creatic cancer is the fourth leading cause of cancer-related deaths in the United States and is nearly s fatal. Whereas… 
2010
2010
wnloaded creatic cancer is the fourth leading cause of cancer-related deaths in the United States and is nearly s fatal. Whereas… 
2007
2007
Purpose:To test whether a novel rexinoid, LG100268, prevents the development of preinvasive and invasive estrogen receptor… 
Review
2007
Review
2007
Purpose:We evaluated the anti-inflammatory and growth-inhibitory properties of the novel rexinoid NRX194204 (4204) in vitro and…